Trial reportJournal of substance use and addiction treatment2026
An economic analysis of Native CHOICES.
Trial report in Journal of substance use and addiction treatment, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
introductionFetal alcohol spectrum disorders (FASDs) are a costly collection of conditions caused by alcohol exposed pregnancies (AEPs). Changing High-Risk Alcohol Use and Increasing Contraception Effectiveness Study (CHOICES) is an evidence-based CDC program for AEP prevention. Native CHOICES is a cultural adaptation of CHOICES shown to be effective for reducing AEP risk in American Indian communities. The current study represents the first economic analysis of Native CHOICES.
methodsUsing pre-pandemic data from a randomized controlled trial of Native CHOICES in a Northern Plains American Indian community, the cost-benefit, cost effectiveness, and quality of adjusted life years (QALY) were assessed for Native CHOICES.
resultsNative CHOICES lowered AEP risk by 18-20 % during the 6 months following program participation, thus lowering FASDs by an estimated 6.84-7.6 %. Economic analysis of Native CHOICES' impact on lowered AEP and FASD risk revealed Native CHOICES' net economic benefit of $308,295 to $376,951 for the 6 months following the program, with cost efficiency ratios for FASDs avoided ranging from $84,887 to $93,709, and $2330 to $2572 per quality adjusted life years gained.
conclusionEconomic analysis results indicate that Native CHOICES is a cost-effective program for AEP and FASD prevention among American Indian participants in the intervention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.